WP only refers to the company as a Structural Heart Company. I believe the mitral repair interest will be our next exciting area. At the time of the AGM they only had 30 percent of the venture. I would like them to get to 80 percent. No doubt we might be creeping up if we are supplying expensive engineering knowhow. That does not come cheap . If it proves disruptive perhaps they could sell it off to fund the pivotal trial. Or sell the TAVR business and keep the mitral.
Further Update on Edwards, page-201
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.92 |
Change
-0.150(0.71%) |
Mkt cap ! $402.0M | |||
| Open | High | Low | Value | Volume |
| $21.00 | $21.00 | $20.70 | $179.1K | 8.618K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $21.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.88 | 1 | 1 |
View Market Depth
| Last trade - 15.59pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$20.93 |
Change
-0.150 ( 0.37 %) |
||||
| Open | High | Low | Volume | ||
| $20.93 | $20.93 | $20.93 | 81 | ||
| Last updated 12.16pm 10/05/2024 ? | |||||
| AVR (ASX) Chart |